Borgman Anne Elizabeth
SEC insider (Form 3/4/5 filer). CIK 0001886388. Director at CURIS INC (CRIS) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in LEXINGTON, MA.
Companies Borgman Anne Elizabeth has filed insider reports for
- CURIS INC (CRIS): Director
- NextCure, Inc. (NXTC): Director
- SUTRO BIOPHARMA, INC. (STRO): Officer, CHIEF MEDICAL OFFICER
Borgman Anne Elizabeth
CIK: 0001886388
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 7, 2026CRIS
CURIS INC
AwardDirectNon Qualified Stock Option
6.8K shares at avg. $5.29- - Jun 18, 2026NXTC
NextCure, Inc.
AwardDirectStock Option (Right to Buy)
2.3K shares- - Jun 20, 2025NXTC
NextCure, Inc.
AwardDirectStock Option (Right to Buy)
18.7K shares- - May 20, 2025CRIS
CURIS INC
AwardDirectNon Qualified Stock Option
14.4K shares at avg. $3.13- - May 1, 2025STRO
SUTRO BIOPHARMA, INC.
Tax PaymentDirect24.7K shares at avg. $1.07$26K - May 1, 2025STRO
SUTRO BIOPHARMA, INC.
ExerciseDirect15.9K shares- - May 1, 2025STRO
SUTRO BIOPHARMA, INC.
ExerciseDirect53.1K shares- - Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
Tax PaymentDirect4.6K shares at avg. $1.59$7K - Mar 1, 2025STRO
SUTRO BIOPHARMA, INC.
ExerciseDirect11.3K shares- - Feb 28, 2025STRO
SUTRO BIOPHARMA, INC.
Tax PaymentDirect15.4K shares at avg. $1.59$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | CRIS CURIS INC | Award Non Qualified Stock Option | 6,800 | $5.29 | - | Direct |
| Jun 18, 2026 | NXTC NextCure, Inc. | Award Stock Option (Right to Buy) | 2,340 | - | - | Direct |
| Jun 20, 2025 | NXTC NextCure, Inc. | Award Stock Option (Right to Buy) | 18,700 | - | - | Direct |
| May 20, 2025 | CRIS CURIS INC | Award Non Qualified Stock Option | 14,400 | $3.13 | - | Direct |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | Tax Payment | 24,709 | $1.07 | $26,439 | Direct |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | Exercise | 15,938 | - | - | Direct |
| May 1, 2025 | STRO SUTRO BIOPHARMA, INC. | Exercise | 53,125 | - | - | Direct |
| Mar 1, 2025 | STRO SUTRO BIOPHARMA, INC. | Tax Payment | 4,621 | $1.59 | $7,347 | Direct |
| Mar 1, 2025 | STRO SUTRO BIOPHARMA, INC. | Exercise | 11,250 | - | - | Direct |
| Feb 28, 2025 | STRO SUTRO BIOPHARMA, INC. | Tax Payment | 15,405 | $1.59 | $24,494 | Direct |
1-10 of 12 transactions